These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1198 related articles for article (PubMed ID: 12907654)
21. eNOS protects prostate cancer cells from TRAIL-induced apoptosis. Tong X; Li H Cancer Lett; 2004 Jul; 210(1):63-71. PubMed ID: 15172122 [TBL] [Abstract][Full Text] [Related]
22. Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells. Gong B; Almasan A Cancer Res; 2000 Oct; 60(20):5754-60. PubMed ID: 11059770 [TBL] [Abstract][Full Text] [Related]
23. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells. Hyer ML; Croxton R; Krajewska M; Krajewski S; Kress CL; Lu M; Suh N; Sporn MB; Cryns VL; Zapata JM; Reed JC Cancer Res; 2005 Jun; 65(11):4799-808. PubMed ID: 15930300 [TBL] [Abstract][Full Text] [Related]
24. Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells. He Q; Huang Y; Sheikh MS Oncogene; 2004 Apr; 23(14):2554-8. PubMed ID: 14691451 [TBL] [Abstract][Full Text] [Related]
25. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K; Douglas L; Delaney A; Houghton JA Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455 [TBL] [Abstract][Full Text] [Related]
26. Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival. Jin H; Yang R; Fong S; Totpal K; Lawrence D; Zheng Z; Ross J; Koeppen H; Schwall R; Ashkenazi A Cancer Res; 2004 Jul; 64(14):4900-5. PubMed ID: 15256461 [TBL] [Abstract][Full Text] [Related]
27. Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L). Ravi R; Bedi A Cancer Res; 2002 Mar; 62(6):1583-7. PubMed ID: 11912124 [TBL] [Abstract][Full Text] [Related]
28. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. Frese S; Frese-Schaper M; Andres AC; Miescher D; Zumkehr B; Schmid RA Cancer Res; 2006 Jun; 66(11):5867-74. PubMed ID: 16740726 [TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer. Li X; Marani M; Yu J; Nan B; Roth JA; Kagawa S; Fang B; Denner L; Marcelli M Cancer Res; 2001 Jan; 61(1):186-91. PubMed ID: 11196158 [TBL] [Abstract][Full Text] [Related]
30. HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2',5'-oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand. Malathi K; Paranjape JM; Ganapathi R; Silverman RH Cancer Res; 2004 Dec; 64(24):9144-51. PubMed ID: 15604285 [TBL] [Abstract][Full Text] [Related]
31. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Keane MM; Ettenberg SA; Nau MM; Russell EK; Lipkowitz S Cancer Res; 1999 Feb; 59(3):734-41. PubMed ID: 9973225 [TBL] [Abstract][Full Text] [Related]
32. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells. Cuello M; Ettenberg SA; Nau MM; Lipkowitz S Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126 [TBL] [Abstract][Full Text] [Related]
33. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells. Sun SY; Yue P; Lotan R Oncogene; 2000 Sep; 19(39):4513-22. PubMed ID: 11002424 [TBL] [Abstract][Full Text] [Related]
34. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO). Ng CP; Bonavida B Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428 [TBL] [Abstract][Full Text] [Related]
35. Effect of Bax deficiency on death receptor 5 and mitochondrial pathways during endoplasmic reticulum calcium pool depletion-induced apoptosis. He Q; Montalbano J; Corcoran C; Jin W; Huang Y; Sheikh MS Oncogene; 2003 May; 22(17):2674-9. PubMed ID: 12730681 [TBL] [Abstract][Full Text] [Related]
36. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways. Shankar S; Singh TR; Fandy TE; Luetrakul T; Ross DD; Srivastava RK Int J Mol Med; 2005 Dec; 16(6):1125-38. PubMed ID: 16273296 [TBL] [Abstract][Full Text] [Related]
37. Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells. Guo F; Sigua C; Tao J; Bali P; George P; Li Y; Wittmann S; Moscinski L; Atadja P; Bhalla K Cancer Res; 2004 Apr; 64(7):2580-9. PubMed ID: 15059915 [TBL] [Abstract][Full Text] [Related]
38. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756 [TBL] [Abstract][Full Text] [Related]
39. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells. Sun SY; Yue P; Zhou JY; Wang Y; Choi Kim HR; Lotan R; Wu GS Biochem Biophys Res Commun; 2001 Jan; 280(3):788-97. PubMed ID: 11162590 [TBL] [Abstract][Full Text] [Related]
40. Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway. Hu H; Jiang C; Schuster T; Li GX; Daniel PT; Lü J Mol Cancer Ther; 2006 Jul; 5(7):1873-82. PubMed ID: 16891474 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]